REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,160,000 | -18.8% | 113,060 | -17.7% | 0.00% | -33.3% |
| Q4 2020 | $3,892,000 | +7.4% | 137,337 | -4.7% | 0.00% | 0.0% |
| Q3 2020 | $3,624,000 | +16.6% | 144,135 | +13.2% | 0.00% | 0.0% |
| Q2 2020 | $3,108,000 | +123.4% | 127,282 | +35.4% | 0.00% | +50.0% |
| Q1 2020 | $1,391,000 | -2.7% | 94,000 | +6.7% | 0.00% | +100.0% |
| Q4 2019 | $1,430,000 | +61.2% | 88,100 | +29.1% | 0.00% | 0.0% |
| Q3 2019 | $887,000 | +39.2% | 68,235 | +39.0% | 0.00% | 0.0% |
| Q2 2019 | $637,000 | -21.9% | 49,100 | -5.1% | 0.00% | 0.0% |
| Q1 2019 | $816,000 | -21.7% | 51,755 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,042,000 | +187.8% | 51,755 | +388.3% | 0.00% | 0.0% |
| Q4 2015 | $362,000 | +18.7% | 10,600 | -32.8% | 0.00% | – |
| Q3 2014 | $305,000 | -10.8% | 15,769 | +56.6% | 0.00% | – |
| Q2 2014 | $342,000 | – | 10,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |